The Continental landscape presents a shifting evolution in the view of psychedelics. Recently stigmatized, these substances are increasingly be explored for their medical applications. From the Netherlands, where clinical trials are being conducted, to the Italy, where awareness is expanding, Europe is at the forefront in this transformation of cop